These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 24491546

  • 1. Phenethyl isothiocyanate sensitizes glioma cells to TRAIL-induced apoptosis.
    Lee DH, Kim DW, Lee HC, Lee JH, Lee TH.
    Biochem Biophys Res Commun; 2014 Apr 18; 446(4):815-21. PubMed ID: 24491546
    [Abstract] [Full Text] [Related]

  • 2. DATS sensitizes glioma cells to TRAIL-mediated apoptosis by up-regulation of death receptor 5 via ROS.
    Hwang JS, Lee YY, Lee DH, Kwon KH.
    Food Chem Toxicol; 2017 Aug 18; 106(Pt A):514-521. PubMed ID: 28571773
    [Abstract] [Full Text] [Related]

  • 3. Phenethyl isothiocyanate enhances TRAIL-induced apoptosis in oral cancer cells and xenografts.
    Yeh CC, Ko HH, Hsieh YP, Wu KJ, Kuo MY, Deng YT.
    Clin Oral Investig; 2016 Dec 18; 20(9):2343-2352. PubMed ID: 26822174
    [Abstract] [Full Text] [Related]

  • 4. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
    Kim EH, Yoon MJ, Kim SU, Kwon TK, Sohn S, Choi KS.
    Cancer Res; 2008 Jan 01; 68(1):266-75. PubMed ID: 18172319
    [Abstract] [Full Text] [Related]

  • 5. Monensin, a polyether ionophore antibiotic, overcomes TRAIL resistance in glioma cells via endoplasmic reticulum stress, DR5 upregulation and c-FLIP downregulation.
    Yoon MJ, Kang YJ, Kim IY, Kim EH, Lee JA, Lim JH, Kwon TK, Choi KS.
    Carcinogenesis; 2013 Aug 01; 34(8):1918-28. PubMed ID: 23615398
    [Abstract] [Full Text] [Related]

  • 6. Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins.
    Park MH, Jo M, Won D, Song HS, Song MJ, Hong JT.
    Apoptosis; 2012 Dec 01; 17(12):1316-26. PubMed ID: 23007278
    [Abstract] [Full Text] [Related]

  • 7. Linarin sensitizes tumor necrosis factor-related apoptosis (TRAIL)-induced ligand-triggered apoptosis in human glioma cells and in xenograft nude mice.
    Xu ZF, Sun XK, Lan Y, Han C, Zhang YD, Chen G.
    Biomed Pharmacother; 2017 Nov 01; 95():1607-1618. PubMed ID: 28950661
    [Abstract] [Full Text] [Related]

  • 8. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
    Yoshida T, Zhang Y, Rivera Rosado LA, Zhang B.
    Mol Cancer Res; 2009 Nov 01; 7(11):1835-44. PubMed ID: 19843632
    [Abstract] [Full Text] [Related]

  • 9. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis.
    Hetschko H, Voss V, Seifert V, Prehn JH, Kögel D.
    FEBS J; 2008 Apr 01; 275(8):1925-36. PubMed ID: 18341587
    [Abstract] [Full Text] [Related]

  • 10. Inostamycin enhanced TRAIL-induced apoptosis through DR5 upregulation on the cell surface.
    Yamamoto K, Makino M, Watanapokasin R, Tashiro E, Imoto M.
    J Antibiot (Tokyo); 2012 Jun 01; 65(6):295-300. PubMed ID: 22472572
    [Abstract] [Full Text] [Related]

  • 11. The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells.
    Fujiwara J, Sowa Y, Horinaka M, Koyama M, Wakada M, Miki T, Sakai T.
    Int J Oncol; 2012 May 01; 40(5):1483-91. PubMed ID: 22328338
    [Abstract] [Full Text] [Related]

  • 12. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells.
    Yang JF, Cao JG, Tian L, Liu F.
    Cancer Chemother Pharmacol; 2012 Jan 01; 69(1):195-206. PubMed ID: 21660448
    [Abstract] [Full Text] [Related]

  • 13. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
    Choi SY, Kim MJ, Chung HY, Lee SJ, Jang YJ.
    Oncol Rep; 2007 Jan 01; 17(1):175-84. PubMed ID: 17143496
    [Abstract] [Full Text] [Related]

  • 14. Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation.
    Kim JY, Kim EH, Kim SU, Kwon TK, Choi KS.
    Carcinogenesis; 2010 Mar 01; 31(3):367-75. PubMed ID: 19939880
    [Abstract] [Full Text] [Related]

  • 15. Verrucarin A sensitizes TRAIL-induced apoptosis via the upregulation of DR5 in an eIF2α/CHOP-dependent manner.
    Moon DO, Asami Y, Long H, Jang JH, Bae EY, Kim BY, Choi YH, Kang CH, Ahn JS, Kim GY.
    Toxicol In Vitro; 2013 Feb 01; 27(1):257-63. PubMed ID: 22982206
    [Abstract] [Full Text] [Related]

  • 16. Aclarubicin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis through death receptor 5 upregulation.
    Horinaka M, Yoshida T, Nakata S, Shiraishi T, Tomosugi M, Yoshikawa S, Wakada M, Sakai T.
    Cancer Sci; 2012 Feb 01; 103(2):282-7. PubMed ID: 22077238
    [Abstract] [Full Text] [Related]

  • 17. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH, Jung EM, Lee TJ, Kim SH, Choi YH, Park JW, Park JW, Choi KS, Kwon TK.
    Free Radic Biol Med; 2008 Mar 15; 44(6):1055-68. PubMed ID: 18164688
    [Abstract] [Full Text] [Related]

  • 18. IFN‑β sensitizes TRAIL‑induced apoptosis by upregulation of death receptor 5 in malignant glioma cells.
    Yoshimura S, Sano E, Hanashima Y, Yamamuro S, Sumi K, Ueda T, Nakayama T, Hara H, Yoshino A, Katayama Y.
    Oncol Rep; 2019 Dec 15; 42(6):2635-2643. PubMed ID: 31638255
    [Abstract] [Full Text] [Related]

  • 19. NVP-BKM120 potentiates apoptosis in tumor necrosis factor-related apoptosis-inducing ligand-resistant glioma cell lines via upregulation of Noxa and death receptor 5.
    Foster KA, Jane EP, Premkumar DR, Morales A, Pollack IF.
    Int J Oncol; 2015 Aug 15; 47(2):506-16. PubMed ID: 26044191
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin sensitizes human hepatocellular carcinoma cells, but not hepatocytes and mesenchymal stem cells, to TRAIL within a therapeutic window partially depending on the upregulation of DR5.
    Zhang B, Shan H, Li D, Li ZR, Zhu KS, Jiang ZB, Huang MS.
    Oncol Rep; 2011 Feb 15; 25(2):461-8. PubMed ID: 21152876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.